News
Hosted on MSN4mon
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiationsThe Centers for Medicare and Medicaid Services (CMS) released its second round of drug negotiation targets, a list of 15 drugs under Medicare Part D, including Novo Nordisk's (NVO) blockbuster GLP-1s.
(Reuters) -All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second round of price talks have agreed to participate in the negotiation ...
March 14 (Reuters) - All drug manufacturers, including Novo Nordisk (NOVOb.CO), opens new tab and Teva Pharmaceuticals (TEVA.TA), opens new tab, whose medicines are part of the second round of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback